Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Morphine as Adjuvants to Bupivacaine in TAP Block
NCT07842861Completed
- Sponsor
- Cairo University
- Start
- Dec 2025
- Primary completion
- Jun 2026
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine in postoperative pain (2 arms), sponsored by Cairo University. Primary endpoint: Duration of analgesia. Started Dec 2025; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07842861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07842861.